CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations
Bin Xue, Yifan Liu, Jie Zhou, Lili Zhou, Shiguang Ye, Yan Lu, Wenjun Zhang, Bing Xiu, Aibin Liang, Ping Li, Ying Lü, Wenbin Qian, Xiu Luo
Topics & Concepts
Chimeric antigen receptorCD19Diffuse large B-cell lymphomaLymphomaRefractory (planetary science)MedicineOncologyCancer researchInternal medicineImmunologyT cellAntigenBiologyImmune systemAstrobiologyCAR-T cell therapy researchLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders research